Your institution may have access to this item. Find your institution then sign in to continue.
Title
Single Molecule Sequencing and the Future.
Abstract
An interview with Stephen Turner, founder and chief technical officer (CTO) at Pacific Biosciences, is presented. Turner stresses the importance of targeted sequencing in humans and in diseases. He notes that the lack of target amplification when utilizing the PacBio RS sequencing system can be an important feature as it can be enabling for some applications. Turner adds that the system has offered a good gauge for determining the time that it takes to introduce new technology in the market.